+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665849
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopharmaceuticals Market size was estimated at USD 574.04 billion in 2023, USD 627.19 billion in 2024, and is expected to grow at a CAGR of 9.74% to reachUSD 1.10 trillion by 2030.

They are comprised of proteins and nucleic acids and are used for therapeutic or diagnostic purposes. Unlike traditional pharmaceuticals, which are chemically synthesized and have well-defined molecular structures, biopharmaceuticals are derived from living organisms. These organisms can include bacteria, yeast, or mammalian cells that are genetically engineered to produce the desired therapeutic substances, such as hormones, antibodies, or vaccines. The rising incidences of chronic and infectious diseases such as cancer, cardiovascular disorders, tuberculosis, Crohn's disease, and arthritis have created a need for novel biopharmaceuticals. Additionally, the expansion of healthcare infrastructure, growing access to healthcare services, and supportive government initiatives that promote the discovery and development of new pharmaceuticals have further generated growth for the industry. However, maintaining cold chain logistics for temperature-sensitive products can prove to be a hurdle for biopharmaceuticals. Furthermore, complexities in manufacturing processes can also significantly impede the widespread growth of the industry. However, key players are investing in new technologies such as AI/ML and data analytics to streamline and accelerate the production of biopharmaceuticals. Moreover, the adoption of personalized medicine and advancement in genomic research can create new opportunities for the growth of the industry.

Regional Insights

The Americas region, particularly the U.S. and Canada, remains a highly advanced region in biopharmaceutical research and development, spurred by a combination of robust intellectual property rights, a science-driven regulatory framework, and a competitive market landscape. The U.S. Food and Drug Administration (FDA) continuously adapts to the rapid pace of innovation, ensuring safe and effective treatments reach patients. The presence of several key players in the biotechnological sector and a robust healthcare infrastructure that provides reimbursements and health insurance have led to the growth of the biopharmaceutical industry. The EU region boasts a robust ground for research and development in the sphere of life sciences and biotechnology. Stringent regulations and standards pertaining to the development of biopharmaceuticals have created a standardized, systematic, and safe environment for innovations in biopharmaceuticals. The European Medicines Agency (EMA) in the EU plays a central role in facilitating the development and accessibility of new therapies. Strong public-private partnerships and a commitment to healthcare innovation define the EU's consumer needs and behavior, which lean towards high-quality, sustainable healthcare solutions. In the APAC region, a growing aging population and government incentives and initiatives for promoting access to affordable healthcare services have led to a need for biopharmaceuticals. Japan, with its established pharmaceutical sector, is characterized by significant spending on healthcare solutions. Countries in the APAC region, such as India and China, have focused on the cost-effective manufacturing of biopharmaceuticals and often invest in biosimilar production.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Biopharmaceuticals Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Prevalence of Chronic Diseases and Need for Targeted Biopharmaceuticals
  • Rising Investments in Vaccine and Drugs Development
  • Attractive Reimbursement Policies for Biopharmaceuticals

Market Restraints

  • Raw Material Supply Chain Disruptions and High Cost of Drug Development

Market Opportunities

  • Advancements in Biopharmaceutical Manufacturing and Testing Technologies
  • Emerging Trends of Outsourcing Biologics and Vaccine Manufacturing

Market Challenges

  • Stringent Regulatory Framework for Drug Manufacturing and Time-Consuming Clinical Trials

Market Segmentation Analysis

  • Product Type: Ongoing R&D initiatives to promote innovations in the field of monoclonal antibodies
  • Services: Need for compendial & multi compendial laboratory testing to ensure compliance with regulations
  • Raw Material Type: Efforts to develop potent APIs to diagnose, cure, or mitigate disease conditions
  • Application: Changes in lifestyles leading to the need for treatment strategies for cardiovascular diseases

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopharmaceuticals Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopharmaceuticals Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion

AstraZeneca entered into a definitive agreement to purchase Icosavax, a vaccine company specializing in the development of candidates designed to combat diseases caused by respiratory viruses, in a deal valued at USD 1.1 billion. This strategic move reflects AstraZeneca's commitment to expanding its vaccine portfolio and also positions the company to enhance its infectious disease capabilities by leveraging Icosavax's vaccine technology.

LEQEMBI Intravenous Infusion (Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20

Eisai Co., Ltd. announced the impending release of their therapy LEQEMBI Intravenous Infusion (lecanemab) in Japan. Formulated as a humanized monoclonal antibody targeting soluble aggregated amyloid-beta (Aβ), this innovative treatment for Alzheimer’s disease has also been included in the Japan National Health Insurance (NHI) Drug Price List. This target-specific, anti-amyloid therapeutic option would be available in two dosage strengths, 200 mg, and 500mg, signifying a major advancement in the management of Alzheimer's disease.

HHS Announces Details of Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies

The U.S. Department of Health and Human Services (HHS) has officially announced refinements to its partnership with biotechnology firm Regeneron Pharmaceuticals in a concerted effort to advance the development of monoclonal antibodies critical for combating COVID-19. This collaboration, fostered under Project NextGen, signifies a strategic move to advance the nation's preparedness against emerging strains and variants of the virus.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopharmaceuticals Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Abgenex, Amgen Inc., AstraZeneca PLC, Avidea Technologies, Bayer AG, Bio-Techne Corporation, Biogen Inc., bioMérieux SA, Bristol-Myers Squibb Company, BTL Biotechno Labs Pvt. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Ferring Pharmaceuticals, GlaxoSmithKline PLC, Ipsen Pharma, Johnson & Johnson Services, Inc., LG Chem Life Sciences Innovation Center, Inc., Merck & Co., Inc., Nordic BioSite, Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type

  • Monoclonal Antibodies
  • Purified Proteins
  • Recombinant Growth Factors
  • Recombinant Hormone
  • Recombinant Proteins
  • Synthetic Immunomodulators
  • Vaccines

Services

  • Compendial & Multi Compendial Laboratory Testing
  • Custom Testing or Customer Proprietary Testing
  • Laboratory Testing

Raw Material Type

  • Active Pharmaceutical Ingredient
  • Formulation Excipients

Application

  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Hormonal Disorders
  • Immunology
  • Inflammatory & Infectious Diseases
  • Metabolic Disorders
  • Neurological Diseases
  • Oncology

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of Chronic Diseases and Need for Targeted Biopharmaceuticals
5.1.1.2. Rising Investments in Vaccine and Drugs Development
5.1.1.3. Attractive Reimbursement Policies for Biopharmaceuticals
5.1.2. Restraints
5.1.2.1. Raw Material Supply Chain Disruptions and High Cost of Drug Development
5.1.3. Opportunities
5.1.3.1. Advancements in Biopharmaceutical Manufacturing and Testing Technologies
5.1.3.2. Emerging Trends of Outsourcing Biologics and Vaccine Manufacturing
5.1.4. Challenges
5.1.4.1. Stringent Regulatory Framework for Drug Manufacturing and Time-Consuming Clinical Trials
5.2. Market Segmentation Analysis
5.2.1. Product Type: Ongoing R&D initiatives to promote innovations in the field of monoclonal antibodies
5.2.2. Services: Need for compendial & multi compendial laboratory testing to ensure compliance with regulations
5.2.3. Raw Material Type: Efforts to develop potent APIs to diagnose, cure, or mitigate disease conditions
5.2.4. Application: Changes in lifestyles leading to the need for treatment strategies for cardiovascular diseases
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Biopharmaceuticals Market, by Product Type
6.1. Introduction
6.2. Monoclonal Antibodies
6.3. Purified Proteins
6.4. Recombinant Growth Factors
6.5. Recombinant Hormone
6.6. Recombinant Proteins
6.7. Synthetic Immunomodulators
6.8. Vaccines
7. Biopharmaceuticals Market, by Services
7.1. Introduction
7.2. Compendial & Multi Compendial Laboratory Testing
7.3. Custom Testing or Customer Proprietary Testing
7.4. Laboratory Testing
8. Biopharmaceuticals Market, by Raw Material Type
8.1. Introduction
8.2. Active Pharmaceutical Ingredient
8.3. Formulation Excipients
9. Biopharmaceuticals Market, by Application
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Cardiovascular Diseases
9.4. Hormonal Disorders
9.5. Immunology
9.6. Inflammatory & Infectious Diseases
9.7. Metabolic Disorders
9.8. Neurological Diseases
9.9. Oncology
10. Americas Biopharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biopharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biopharmaceuticals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
13.3.2. LEQEMBI Intravenous Infusion (Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20
13.3.3. HHS Announces Details of Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. BIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. BIOPHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPHARMACEUTICALS MARKET DYNAMICS
FIGURE 7. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT HORMONE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT HORMONE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SYNTHETIC IMMUNOMODULATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SYNTHETIC IMMUNOMODULATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COMPENDIAL & MULTI COMPENDIAL LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COMPENDIAL & MULTI COMPENDIAL LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CUSTOM TESTING OR CUSTOMER PROPRIETARY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CUSTOM TESTING OR CUSTOMER PROPRIETARY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY FORMULATION EXCIPIENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY FORMULATION EXCIPIENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY & INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY & INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 82. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 83. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 84. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 85. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 86. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 87. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 92. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 93. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 94. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 95. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 126. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 127. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 128. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 129. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 130. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 131. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 134. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 135. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 136. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 137. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 138. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 139. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 144. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 145. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 146. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 147. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 150. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 151. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 152. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 153. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 154. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 155. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 159. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 160. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 161. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 162. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 163. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 167. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 168. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 169. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 170. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 171. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 175. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 176. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 177. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 178. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 179. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 183. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 184. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 185. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 186. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 187. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 191. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 192. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 193. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 194. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 195. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 198. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 199. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 200. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 201. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 202. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 203. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 207. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 208. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 209. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 210. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 211. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 223. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 224. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 225. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 226. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 227. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 228. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 229. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 232. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 233. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 234. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 235. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 236. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 237. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 240. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 241. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 242. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 243. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 244. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 245. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 248. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 249. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 250. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 251. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 252. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 253. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 256. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 257. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 258. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 259. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 260. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 261. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 265. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 266. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 267. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 268. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 269. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 272. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 273. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 274. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 275. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 276. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 277. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 281. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 282. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 283. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 284. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 285. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 289. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 290. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 291. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 292. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 293. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 296. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 297. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 298. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 299. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 300. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 301. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 304. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 305. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 306. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 307. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 308. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 309. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 312. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 313. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 314. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 315. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 316. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 317. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 320. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 321. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 322. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 323. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 324. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 325. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 328. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 330. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 332. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 336. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 338. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2023 (USD MILLION)
TABLE 340. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2024-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 344. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 345. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 346. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES,

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Abgenex
  • Amgen Inc.
  • AstraZeneca PLC
  • Avidea Technologies
  • Bayer AG
  • Bio-Techne Corporation
  • Biogen Inc.
  • bioMérieux SA
  • Bristol-Myers Squibb Company
  • BTL Biotechno Labs Pvt. Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals
  • GlaxoSmithKline PLC
  • Ipsen Pharma
  • Johnson & Johnson Services, Inc.
  • LG Chem Life Sciences Innovation Center, Inc.
  • Merck & Co., Inc.
  • Nordic BioSite
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 627.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 1100.51 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal

Related Topics

Related Reports

North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - Product Image

North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • Report
  • 224 Pages
  • North America
From
Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - Product Image

Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • Report
  • 250 Pages
  • Asia Pacific
From
Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Training Course (November 18-19, 2024) - Product Image

Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Training Course (November 18-19, 2024)

  • Conference
  • 2 Days
  • Global
Global Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Forecast 2024-2030 - Product Image

Global Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Non-Mammalian), Services, Scale of Operation, Therapeutic Applications - Forecast 2024-2030 - Product Image

Global Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Non-Mammalian), Services, Scale of Operation, Therapeutic Applications - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From

About the Biopharmaceuticals Market

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.